{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:52:02Z","timestamp":1790268722079,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1007\/s12325-016-0282-0","type":"journal-article","created":{"date-parts":[[2016,1,30]],"date-time":"2016-01-30T09:09:58Z","timestamp":1454144998000},"page":"214-224","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Assessing Changes in Chronic Spontaneous\/Idiopathic Urticaria: Comparisons of Patient-Reported Outcomes Using Latent Growth Modeling"],"prefix":"10.1007","volume":"33","author":[{"given":"Donald E.","family":"Stull","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doreen","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Houghton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew Y.","family":"Finlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ari","family":"Gnanasakthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Magdalena","family":"Balp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,30]]},"reference":[{"issue":"7","key":"282_CR1","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/all.12313","volume":"69","author":"T Zuberbier","year":"2014","unstructured":"Zuberbier T, Aberer W, Asero R, et al. The EAACI\/GA(2) LEN\/EDF\/WAO guideline for the definition, classification, diagnosis, and management of urticaria: the 2013 revision and update. Allergy. 2014;69(7):868\u201387.","journal-title":"Allergy"},{"issue":"2","key":"282_CR2","first-page":"93","volume":"21","author":"B T\u00f6ndury","year":"2011","unstructured":"T\u00f6ndury B, Muehleisen B, Ballmer-Weber BK, et al. The Pictorial Representation of Illness and Self Measure (PRISM) instrument reveals a high burden of suffering in patients with chronic urticaria. J Investig Allergol Clin Immunol. 2011;21(2):93\u2013100.","journal-title":"J Investig Allergol Clin Immunol"},{"issue":"10","key":"282_CR3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/ddg.12194_suppl","volume":"11","author":"M Maurer","year":"2013","unstructured":"Maurer M, Magerl M, Metz M, et al. Revisions to the international guidelines on the diagnosis and therapy of chronic urticaria. J Dtsch Dermatol Ges. 2013;11(10):971\u20138.","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"282_CR4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1398-9995.2010.02496.x","volume":"66","author":"M Maurer","year":"2011","unstructured":"Maurer M, Weller K, Bindslev-Jensen C, et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report. Allergy. 2011;66(3):317\u201330.","journal-title":"Allergy"},{"issue":"2","key":"282_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2133.1997.d01-1168.x","volume":"136","author":"BF O\u2019Donnell","year":"1997","unstructured":"O\u2019Donnell BF, Lawlor F, Simpson J, et al. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136(2):197\u2013201.","journal-title":"Br J Dermatol"},{"issue":"2","key":"282_CR6","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1111\/j.1365-2133.2005.06976.x","volume":"154","author":"P Staubach","year":"2006","unstructured":"Staubach P, Eckhardt-Henn A, Dechene M, et al. Quality of life in patients with chronic urticaria is differentially impaired and determined by psychiatric comorbidity. Br J Dermatol. 2006;154(2):294\u20138.","journal-title":"Br J Dermatol"},{"issue":"7","key":"282_CR7","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/j.1398-9995.2011.02580.x","volume":"66","author":"I Baiardini","year":"2011","unstructured":"Baiardini I, Braido F, Bindslev-Jensen C, et al. Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2)LEN taskforce position paper. Allergy. 2011;66(7):840\u20134.","journal-title":"Allergy"},{"issue":"1","key":"282_CR8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0895-4356(02)00537-1","volume":"56","author":"S Wiebe","year":"2003","unstructured":"Wiebe S, Guyatt G, Weaver B, et al. Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol. 2003;56(1):52\u201360.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"282_CR9","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000351711","volume":"226","author":"I Koti","year":"2013","unstructured":"Koti I, Weller K, Makris M, et al. Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria. Dermatology. 2013;226(4):371\u20139.","journal-title":"Dermatology"},{"key":"282_CR10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cct.2009.12.006","volume":"31","author":"DE Stull","year":"2010","unstructured":"Stull DE, Vernon MK, Legg JC, et al. Use of latent growth curve models for assessing the effects of darbepoetin alfa on hemoglobin and fatigue. Contemp Clin Trials. 2010;31:172\u20139.","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"282_CR11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/jid.2014.306","volume":"135","author":"SS Saini","year":"2015","unstructured":"Saini SS, Bindslev-Jensen C, Maurer M, et al. Efficacy and safety of omalizumab in patients with chronic idiopathic\/spontaneous urticaria who remain symptomatic on H1 antihistamines: a randomized, placebo-controlled study. J Invest Dermatol. 2015;135(1):67\u201375.","journal-title":"J Invest Dermatol"},{"issue":"10","key":"282_CR12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","volume":"368","author":"M Maurer","year":"2013","unstructured":"Maurer M, Ros\u00e9n K, Hsieh HJ, et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013;368(10):924\u201335.","journal-title":"N Engl J Med"},{"issue":"1","key":"282_CR13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaci.2013.05.013","volume":"132","author":"A Kaplan","year":"2013","unstructured":"Kaplan A, Ledford D, Ashby M, et al. Omalizumab in patients with symptomatic chronic idiopathic\/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013;132(1):101\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"282_CR14","doi-asserted-by":"crossref","unstructured":"World Medical Association. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects. Seoul, South Korea: World Medical Association, October 2008.","DOI":"10.1515\/9783110208856.233"},{"issue":"2","key":"282_CR15","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.anai.2010.06.011","volume":"105","author":"SD Mathias","year":"2010","unstructured":"Mathias SD, Dreskin SC, Kaplan A, et al. Development of a daily diary for patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2010;105(2):142\u20138.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"282_CR16","doi-asserted-by":"crossref","unstructured":"Mathias SD, Crosby RD, Rosen K, et al. Estimating the minimal important difference (MID) of the measures in the Urticaria Patient Daily Diary (UPDD): updated findings using data from the Asteria I, Asteria II, and Glacial studies of omalizumab in chronic idiopathic\/spontaneous urticaria. J Allergy Clin Immunol. 2014;133(suppl 2):AB118.","DOI":"10.1016\/j.jaci.2013.12.438"},{"key":"282_CR17","unstructured":"Zazzali JL, Mathias SD, Flood EM, et al. Development and validation of the Urticaria Patient Daily Diary (UPDD). In: Presented at the 4th International Consensus Meeting on Urticaria; Berlin, Germany. 28\u201329 November 2012."},{"issue":"3","key":"282_CR18","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","volume":"19","author":"AY Finlay","year":"1994","unstructured":"Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)\u2014a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210\u20136.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"282_CR19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S1081-1206(10)61466-4","volume":"93","author":"RD Lennox","year":"2004","unstructured":"Lennox RD, Leahy MJ. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life. Ann Allergy Asthma Immunol. 2004;93(2):142\u20136.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"282_CR20","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1477-7525-3-36","volume":"3","author":"R Shikiar","year":"2005","unstructured":"Shikiar R, Harding G, Leahy M, et al. Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria. Health Qual Life Outcomes. 2005;3:36.","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"282_CR21","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1398-9995.2005.00833.x","volume":"60","author":"I Baiardini","year":"2005","unstructured":"Baiardini I, Pasquali M, Braido F, et al. A new tool to evaluate the impact of chronic urticaria on quality of life: Chronic Urticaria Quality of Life Questionnaire (CU-QoL). Allergy. 2005;60(8):1073\u20138.","journal-title":"Allergy"},{"issue":"1","key":"282_CR22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11136-007-9290-5","volume":"17","author":"DE Stull","year":"2008","unstructured":"Stull DE. Analyzing growth and change: latent variable growth curve modelling with an application to clinical trials. Qual Life Res. 2008;17(1):47\u201359.","journal-title":"Qual Life Res"},{"key":"282_CR23","unstructured":"Muth\u00e9n LK, Muth\u00e9n BO. Mplus User\u2019s Guide. 6th ed. Los Angeles: Muth\u00e9n & Muth\u00e9n; 1998\u20132010."},{"issue":"6","key":"282_CR24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1111\/j.1398-9995.2008.01726.x","volume":"63","author":"A M\u0142ynek","year":"2008","unstructured":"M\u0142ynek A, Zalewska-Janowska A, Martus P, et al. How to assess disease activity in patients with chronic urticaria? Allergy. 2008;63(6):777\u201380.","journal-title":"Allergy"},{"issue":"7","key":"282_CR25","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2230.2012.04414.x","volume":"37","author":"YM Ye","year":"2012","unstructured":"Ye YM, Park JW, Kim SH, et al. Clinical evaluation of the computerized chronic urticaria-specific quality of life questionnaire in Korean patients with chronic urticaria. Clin Exp Dermatol. 2012;37(7):722\u20138.","journal-title":"Clin Exp Dermatol"},{"key":"282_CR26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/jncimonographs\/lgm005","volume":"37","author":"CS Cleeland","year":"2007","unstructured":"Cleeland CS. Quality of life assessment in symptom management trials: symptom burden: multiple symptoms and their impact as patient-reported outcomes. J Natl Cancer Inst Monogr. 2007;37:16\u201321.","journal-title":"J Natl Cancer Inst Monogr"},{"key":"282_CR27","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/jid.2011.354","volume":"132","author":"T Nijsten","year":"2012","unstructured":"Nijsten T. Dermatology Life Quality Index: time to move forward. J Invest Dermatol. 2012;132:11\u20133.","journal-title":"J Invest Dermatol"},{"key":"282_CR28","first-page":"997","volume":"159","author":"MKA Basra","year":"2008","unstructured":"Basra MKA, Fenech R, Gatt RM, et al. The Dermatology Life Quality Index 1994\u20132007: a comprehensive review of validation data and clinical results. Br J Dermatol. 2008;159:997\u20131035.","journal-title":"Br J Dermatol"},{"key":"282_CR29","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1038\/jid.2012.147","volume":"132","author":"AY Finlay","year":"2012","unstructured":"Finlay AY, Basra MKA, Piguet V, Salek S. DLQI: a paradigm shift to patient-centred outcomes. J Invest Dermatol. 2012;132:2464\u20135.","journal-title":"J Invest Dermatol"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-016-0282-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T00:30:14Z","timestamp":1567557014000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-016-0282-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,30]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1007\/s12325-016-0282-0","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,30]]}}}